Albert Bourla, Pfizer CEO (Evan Vucci/AP Images)
July 6, 2021 07:08 AM EDT
Coronavirus

Covid-19 roundup: Is­rael and South Ko­rea ne­go­ti­ate vac­cine swap; Af­ter av­do­ral­imab fail­ure, In­nate aban­dons pan­dem­ic work

Josh Sullivan

Is­rael is ship­ping 700,000 dos­es of Pfiz­er-BioN­Tech’s mR­NA-based vac­cine to South Ko­rea for dos­es to be named lat­er.

South Ko­rea will send a ship­ment of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times